BioPharma Resources

Drug Trial Radar · NCT06283966

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease (THARROS)

Last checked: Nov 19, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 5,250 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

5,250

Planned (sponsor's estimate)

Start

Feb 21, 2024

Primary completion

Dec 3, 2027

Study completion Dec 3, 2027

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Feb 28, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg in a population with COPD and elevated cardiopulmonary risk.

Conditions

  • COPD (Chronic Obstructive Pulmonary Disease)

Interventions

  • BGF MDI 320/14.4/9.6 μgDrug

    Budesonide, glycopyrronium, and formoterol fumarate pressurized inhalation suspension

  • GFF MDI 14.4/9.6 μgDrug

    Glycopyrronium and formoterol fumarate pressurized inhalation suspension

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to first severe cardiac or COPD eventTime frame: Up to 3 years

Locations

922 sites in 37 countries. Site status is shown where the registry gives one.

  • Research Site

    Athens, Alabama · Terminated

  • Research Site

    Cullman, Alabama · Recruiting

  • Research Site

    Fairhope, Alabama · Terminated

  • Research Site

    Huntsville, Alabama · Terminated

  • Research Site

    Mobile, Alabama · Recruiting

  • Research Site

    Sheffield, Alabama · Withdrawn

  • Research Site

    Gilbert, Arizona · Recruiting

  • Research Site

    Glendale, Arizona · Withdrawn

  • Research Site

    Mesa, Arizona · Recruiting

  • Research Site

    Mesa, Arizona · Recruiting

  • Research Site

    Phoenix, Arizona · Terminated

  • Research Site

    Tempe, Arizona · Suspended

  • Research Site

    Tempe, Arizona · Terminated

  • Research Site

    Tucson, Arizona · Recruiting

  • Research Site

    Tucson, Arizona · Recruiting

  • Research Site

    Apple Valley, California · Withdrawn

  • Research Site

    Canoga Park, California · Suspended

  • Research Site

    Castroville, California · Recruiting

  • Research Site

    Garden Grove, California · Recruiting

  • Research Site

    Gardena, California · Terminated

  • Research Site

    Inglewood, California · Recruiting

  • Research Site

    La Mesa, California · Recruiting

  • Research Site

    La Palma, California · Recruiting

  • Research Site

    Lomita, California · Recruiting

  • Research Site

    Long Beach, California · Recruiting

  • Research Site

    Los Alamitos, California · Terminated

  • Research Site

    Mission Viejo, California · Recruiting

  • Research Site

    Newport Beach, California · Recruiting

  • Research Site

    North Hollywood, California · Terminated

  • Research Site

    Pomona, California · Recruiting

  • Research Site

    Sacramento, California · Recruiting

  • Research Site

    Sacramento, California · Recruiting

  • Research Site

    San Bernardino, California · Terminated

  • Research Site

    San Diego, California · Terminated

  • Research Site

    San Dimas, California · Withdrawn

  • Research Site

    Santa Ana, California · Withdrawn

  • Research Site

    Tarzana, California · Recruiting

  • Research Site

    Thousand Oaks, California · Recruiting

  • Research Site

    Van Nuys, California · Withdrawn

  • Research Site

    Vista, California · Recruiting

Showing 40 of 922 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.